Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Allergan
>
Cost cuts are coming for Allergan, CEO Brent Saunders says
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 5953764"]Heading into Allergan’s third-quarter conference call, executives knew investors were skittish about the prospect of Restasis generics. So they spelled out their solution loud and clear: Cost cuts are coming, and “rapidly.”</p><p><br /></p><p>Executives are currently sifting through the details of cost-squeezing proposals they drew up earlier this year, CEO Brent Saunders said on the call. And considering Allergan’s experience wringing savings out of its many M&A deals, investors shouldn’t worry. When it was Actavis, the company <a href="http://www.fiercepharma.com/corporate/allergan-to-cut-loose-577-more-workers-irvine" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://www.fiercepharma.com/corporate/allergan-to-cut-loose-577-more-workers-irvine" rel="nofollow">slashed</a> 577 jobs at its Irvine, CA headquarters alone as part of the $1.8 billion in savings it plotted when it took over Allergan.</p><p><br /></p><p>“This team is up for it,” Saunders said. “I hate to say we know how to take costs out of the business, but we do, and we know how to do that in a way that protects the long-term growth drivers.”[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 5953764"]Heading into Allergan’s third-quarter conference call, executives knew investors were skittish about the prospect of Restasis generics. So they spelled out their solution loud and clear: Cost cuts are coming, and “rapidly.” Executives are currently sifting through the details of cost-squeezing proposals they drew up earlier this year, CEO Brent Saunders said on the call. And considering Allergan’s experience wringing savings out of its many M&A deals, investors shouldn’t worry. When it was Actavis, the company [URL='http://www.fiercepharma.com/corporate/allergan-to-cut-loose-577-more-workers-irvine']slashed[/URL] 577 jobs at its Irvine, CA headquarters alone as part of the $1.8 billion in savings it plotted when it took over Allergan. “This team is up for it,” Saunders said. “I hate to say we know how to take costs out of the business, but we do, and we know how to do that in a way that protects the long-term growth drivers.”[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Allergan
>
Cost cuts are coming for Allergan, CEO Brent Saunders says
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Allergan
>
Cost cuts are coming for Allergan, CEO Brent Saunders says
>